4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000032
Director sold 1,546 shares at $99.16 ($153,301)
- Director acquired 1,546 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CARTER BRUCE L A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-11 | Exercise or conversion : show line 1 in the form | +1,546 | $23.40 | $36,176 | 1,546 | D |
| 2019-03-11 | Sale : show line 2 in the form | −1,546 | $99.16 | $153,301 | 0 | D |
| Open-market sales · 1,546 sh · avg $99.16 · $153,301 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-11 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,546 | $23.40 | 2023-11-22 | 1,546 | 0 | D |
Loading xslF345X03/edgar.xml…